Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Share Facebook Twitter LinkedIn Pinterest Email THE HERD WITH COLIN COWHERD Trending MLB NFL Gold Cup UFL INDYCAR NASCAR LIV NBA NHL PGA NCAAFB
